Justin Klein, cofounder and Managing Partner at Vensana Capital, a top venture capital and growth investment firm focused on funding innovation in the medical technology world, discusses the Medicare Coverage of Innovative Technologies (MCIT) rule and the role venture capital firms like his play overall in the process of bringing promising new medical technologies to market.

Conversation with Justin Klein of Vensana

Brought to you by the AdvaMed, the Medtech Association, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medical technology and policy from every perspective.
Tune in to each episode for interesting discussions with medical technology and health care leaders on issues that are driving the day—from business, to policy, and current events, all viewed through the lens of the medtech industry.
Learn more about AdvaMed at www.advamed.org.

Business

Health & Fitness

Technology

Brought to you by the AdvaMed, the Medtech Association, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medical technology and policy from every perspective. Tune in to each episode for interesting discussions with medical technology and health care leaders on issues that are driving the day—from business, to policy, and current events, all viewed through the lens of the medtech industry. Learn more about AdvaMed at www.advamed.org.

Share Conversation with Justin Klein of Vensana

Sign up to save your podcasts

Conversation with Justin Klein of Vensana

Conversation with Justin Klein of Vensana